Clinical Trials & Tribulations: Tales of 21st Century Drug Development
- Navigating Clinical Trial Challenges – Insights on patient recruitment, regulatory hurdles, funding constraints, and managing trial complexity.
- Innovations and Emerging Trends – The role of technology, decentralized trials, patient-centric approaches, and the future of clinical research.
- Ethical and Strategic Considerations – Diversity in trials, handling adverse events, sponsor-CRO collaboration, and lessons learned from real-world experiences.
Speakers
Robin Hume – M
oderator
Head of Regulatory Affairs and Quality Assurance, Lava Therapeutics
Kimberley Buytaert-Hoefen, Ph.D
COO, Versiti Clinical Trial Services, Pearl Pathways
Dr. Amy R. Lankford
SVP, Head of Clinical Operations and Regulatory Affairs, Precigen
Bryan Manning
Founder and CEO, Clinical Enrollment
Joel Selzer
CEO, ArcheMedX
Thanks to our Event Sponsor Versiti Clinical Trials